FDA 483 Observations in the Laboratory. What went wrong? How can they be avoided?

FDA 483 Observations in the Laboratory. What went wrong? How can they be avoided? - Webinar By GlobalCompliancePanel

10 January 2012, Wilmington, United States

Introduction

In order to proactively address areas of concern to the FDA and other regulators, All units within each pharmaceutical firm should review recent regulatory observations and proactively establish programs or systems to address the regulatory concerns.

Useful links

Venue

online training

online training, DE, 1000 N West Street, Wilmington, 19801, United States

Useful links

Organised by

GlobalCompliancePanel

Contact information

Mr webinars web
Online Training, 1000 N West Street Suite,, Suite 1200, Wilmington, 19801, United States of America
8004479407
Contact us by email

91AV

Share: